DanGer shock criteria and outcomes in acute myocardial infarction-related cardiogenic shock treated with Impella: the J-PVAD registry
In this nationwide registry, one-third of AMI-CS patients treated with Impella met DanGer shock criteria. Outcomes in non-eligible subgroups were heterogeneous, highlighting the importance of individualized risk assessment in guiding Impella use in real-world practice.
Authors
- Yasuo Okumura (ORCID: https://orcid.org/0000-0002-2960-4241)
- Keisuke Kojima (ORCID: https://orcid.org/0000-0001-8430-384X)
- Riku Arai (ORCID: https://orcid.org/0000-0003-0995-5957)
- Daisuke Fukamachi (ORCID: https://orcid.org/0000-0002-9647-3077)
Institutions
- Nihon University (JP)
Publication Details
- Journal
- European Heart Journal
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1093/eurheartj/ehaf787
- Citations
- 4
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 2.70
Funders
- Abiomed
- Japanese Circulation Society